BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05843448-completion@plaintrial.com
DTSTAMP:20261028T135935Z
DTSTART;VALUE=DATE:202612
SUMMARY:IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO
 103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant\
 , Non-Muscle Invasive Bladder Cancer — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05843448
URL:https://plaintrial.com/trial/NCT05843448
END:VEVENT
END:VCALENDAR
